NASDAQ: RAREUltragenyx Pharmaceutical Inc Stock Ownership - Who owns Ultragenyx Pharmaceutical?
Insider buying vs selling
Have Ultragenyx Pharmaceutical Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Howard Horn | Chief Financial Officer | 2026-07-01 | 4,698 | $33.13 | $155.64kSell |
| Corazon Corsee D. Sanders | Director | 2026-06-15 | 2,000 | $25.05 | $50.10kSell |
| Karah Herdman Parschauer | EVP and Chief Legal Officer | 2026-06-15 | 1,899 | $24.62 | $46.75kSell |
| Howard Horn | Chief Financial Officer | 2026-06-01 | 4,653 | $23.77 | $110.60kSell |
| Shehnaaz Suliman | Director | 2026-05-18 | 5,740 | $25.12 | $144.19kSell |
| Eric Crombez | EVP and Chief Medical Officer | 2026-05-05 | 344 | $24.96 | $8.59kSell |
| Howard Horn | Chief Financial Officer | 2026-05-01 | 4,683 | $24.90 | $116.61kSell |
| Howard Horn | Chief Financial Officer | 2026-04-01 | 4,683 | $20.97 | $98.20kSell |
| Karah Herdman Parschauer | EVP and Chief Legal Officer | 2026-03-10 | 3,508 | $22.67 | $79.53kSell |
| Karah Herdman Parschauer | EVP and Chief Legal Officer | 2026-03-06 | 6,018 | $21.40 | $128.79kSell |
RARE insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when RARE insiders and whales buy or sell their stock.
RARE Shareholders
What type of owners hold Ultragenyx Pharmaceutical Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Emil D. Kakkis | 9.48% | 9,341,679 | $243.26M | Insider |
| Blackrock Inc | 7.41% | 7,299,598 | $190.08M | Institution |
| Vanguard Portfolio Management LLC | 5.47% | 5,385,992 | $140.25M | Institution |
| State Street Corp | 5.10% | 5,021,441 | $130.76M | Institution |
| Fmr LLC | 4.79% | 4,718,234 | $122.86M | Insider |
| Aqr Capital Management LLC | 4.65% | 4,578,024 | $119.21M | Institution |
| Vanguard Capital Management LLC | 4.25% | 4,189,831 | $109.10M | Institution |
| Rtw Investments LP | 3.70% | 3,648,795 | $95.01M | Institution |
| Sands Capital Management LLC | 3.26% | 3,214,533 | $83.71M | Institution |
| Sofinnova Investments Inc | 3.19% | 3,145,888 | $81.92M | Institution |
RARE vs Biotech Stocks
Ultragenyx Pharmaceutical Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.